{"category": "ham", "to_address": "Sue Rochman <sue.rochman@earthlink.net>,\n   IP-Health <Ip-health@lists.essential.org>", "from_address": "Spielas Ball <spielasball@yahoo.co.uk>", "subject": "Re: [Ip-health] drug naming/patents/exclusivity", "body": "There is the example of celecoxib which is marketed as Celebrex and as Onsenal - the latter specifically for familial adenomatous polyposis.\n\nRegards\nSpielas Ball\n---------\nFaculty of Pharmacy\nKuwait University\nspielasball[AT]yahoo.co.uk\n\n\n\n\n\n      ___________________________________________________________\nYahoo! Mail is the world's favourite email. Don't settle for less, sign up for\nyour free account today http://uk.rd.yahoo.com/evt=44106/*http://uk.docs.yahoo.com/mail/winter07.html\n_______________________________________________\nIp-health mailing list\nIp-health@lists.essential.org\nhttp://lists.essential.org/mailman/listinfo/ip-health\n\n"}